61 related articles for article (PubMed ID: 4034213)
41. Serum binding of calcium and the red cell membrane in cystic fibrosis.
Fitzpatrick DF; Landon EJ; James V
Nat New Biol; 1972 Feb; 235(58):173-4. PubMed ID: 4501202
[No Abstract] [Full Text] [Related]
42. Cystic fibrosis and fast moving haemoglobin.
Moses RG; Bowen T; Edwards R
Med J Aust; 1978 Aug; 2(4):160-1. PubMed ID: 723719
[No Abstract] [Full Text] [Related]
43. Letter: Essential fatty acids and cystic fibrosis.
McEvoy FA
Lancet; 1975 Aug; 2(7927):236. PubMed ID: 51999
[No Abstract] [Full Text] [Related]
44. Alternative complement pathway activity in cystic fibrosis.
Lyrene RK; Polhill RB; Guthrie LA; Tiller RE
J Pediatr; 1977 Oct; 91(4):681-2. PubMed ID: 908997
[No Abstract] [Full Text] [Related]
45. Patterns of acid-induced release endogenous immunoreactive secretin in children with cystic fibrosis and recurrent pain.
McKiernan J; Johnston DI; Hiller EJ
Ir J Med Sci; 1981 Mar; 150(3):66-8. PubMed ID: 7228600
[No Abstract] [Full Text] [Related]
46. Serum protein paper electrophoresis in patients with cystic fibrosis.
GREEN MN; KULCZYCKI LL; SHWACHMAN H
Am J Dis Child; 1960 Sep; 100():365-72. PubMed ID: 13851517
[No Abstract] [Full Text] [Related]
47. [Electrophoretic mobility of erythrocytes as an indicator of evaluation of the functional intactness of erythrocyte membranes].
Purlo NV; Popova OV; Biriukova LS; Kozinets GI
Klin Lab Diagn; 2005 Jan; (1):40-4. PubMed ID: 15765654
[No Abstract] [Full Text] [Related]
48. New device for determination of cell electrophoretic mobility using doppler velocimetry.
Malher E; Martin D; Duvivier C; Volochine B; Stoltz JF
Biorheology; 1982; 19(5):647-54. PubMed ID: 7150717
[TBL] [Abstract][Full Text] [Related]
49. Abnormal electrophoretic mobility of erythrocytes in cystic fibrosis: evidence for a membrane defect.
Hein J; Seyfarth M; Jenssen HL; Köhler HJ
Padiatr Grenzgeb; 1985; 24(4):331-40. PubMed ID: 4034213
[No Abstract] [Full Text] [Related]
50. [Demonstration of cell membrane potential disorder of erythrocytes in cystic fibrosis using strophanthin test].
Seyfarth M; Jenssen HL; Hein J; Köhler H
Kinderarztl Prax; 1977 Dec; 45(12):535-9. PubMed ID: 609196
[No Abstract] [Full Text] [Related]
51. [Clinical value of changes in red blood cell ultrastructure and energy metabolism in children with cystic fibrosis].
Badriashvili NR; Chikovani MM; Topuridze MA; Glonti SZ; Sharikadze NV; Topuria TIu; Pagava KI
Georgian Med News; 2011 Apr; (193):30-4. PubMed ID: 21617271
[TBL] [Abstract][Full Text] [Related]
52. [Clinical significance of the changes in the ultrastructure and the energy system of erythrocytes in children with mucoviscidosis].
Badriashvili NR; Kvachadze IM; Korobko IuA; Kapranov NI; Niiazova MKh
Pediatriia; 1987; (10):43-8. PubMed ID: 3696858
[No Abstract] [Full Text] [Related]
53. Measuring the impedance of erythrocytes in patients with cystic fibrosis.
Zöllner H; König A; Jährig K
Acta Univ Carol Med (Praha); 1990; 36(1-4):58-61. PubMed ID: 2130719
[TBL] [Abstract][Full Text] [Related]
54. [Clinical value of changes in red blood cell ultrastructure and energy metabolism in children with cystic fibrosis of the pancreas].
Badriashvili NR; Topuridze NL; Chakhunashvili GS; Tabutsadze DO; Khvitisiashvili NO
Georgian Med News; 2006 Jun; (135):73-8. PubMed ID: 16905815
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
